Form 4: DENTSPLY SIRONA Director Buys 10,000 Shares

DENTSPLY SIRONA Director Brian P. McKeon acquired 10,000 shares of common stock through a trust, signaling confidence.

Summary

• Brian P. McKeon, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 10,000 shares of common stock.
• The acquisition occurred on June 12, 2026, at a price of $10.12 per share.
• These 10,000 shares are beneficially owned indirectly through a trust.
• Following this transaction, Mr. McKeon beneficially owns 10,000 shares indirectly through a trust and 28,887 shares directly.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal, as insider buying often reflects management's conviction in the company's intrinsic value and future growth potential.

Positives

• A company director, Brian P. McKeon, acquired 10,000 shares of DENTSPLY SIRONA Inc. common stock, signaling confidence in the company's future.
• The acquisition was made at a price of $10.12 per share.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider purchases, especially by directors, can be interpreted by the market as a positive signal regarding the company's future prospects and valuation, often indicating management's belief that the stock is undervalued or poised for growth.

Related Party Transactions

• The acquisition of 10,000 shares was made indirectly through a trust, which is a common arrangement for insider holdings.

Stakeholder Impact

• Shareholders: May view the insider purchase as a positive sign, potentially increasing confidence and demand for the stock.

Key Dates

Recommendation

The acquisition of 10,000 shares by a director at $10.12 per share indicates strong insider confidence in DENTSPLY SIRONA Inc.'s future prospects and valuation, suggesting the stock may be undervalued. This insider buying activity typically signals a positive outlook to the market.

Keywords

DENTSPLY SIRONA, XRAY, insider trading, stock acquisition, director, common stock, Form 4